Zim Laboratories Limited has announced the outcome of its Board Meeting held on January 21, 2026. The Board has approved the raising of funds through a preferential issue on a private placement basis. The company plans to issue and allot up to 47,64,497 equity shares, each with a face value of ₹10, at an issue price of ₹73.46 per share. This move is expected to raise a total of approximately ₹34.99 crore. The preferential issue will be made to Florintree Trinex LLP, a limited liability partnership that is not part of the promoter group. The approval for this preferential issue is subject to obtaining necessary shareholder and regulatory approvals. To facilitate this fundraising, the Board has also approved convening an extraordinary general meeting (EGM) of the shareholders on February 16, 2026. The EGM will be held through video conferencing/other audio-visual means to seek shareholder approval for the preferential issue. The draft EGM notice and related documents have also been approved.
